These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1427983)

  • 1. Retention of tissue-specific phenotype in a panel of colon carcinoma cell lines: relationship to clinical correlates.
    Whitehead RH; Zhang HH; Hayward IP
    Immunol Cell Biol; 1992 Aug; 70 ( Pt 4)():227-36. PubMed ID: 1427983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines.
    Chantret I; Barbat A; Dussaulx E; Brattain MG; Zweibaum A
    Cancer Res; 1988 Apr; 48(7):1936-42. PubMed ID: 3349466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY; Shamsuddin AM
    Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of colonic growth factors using a human colonic carcinoma cell line (LIM1215).
    Whithead RH; Nice EC; Lloyd CJ; James R; Burgess AW
    Int J Cancer; 1990 Nov; 46(5):858-63. PubMed ID: 2228314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells.
    Rodrigues S; Rodrigue CM; Attoub S; Fléjou JF; Bruyneel E; Bracke M; Emami S; Gespach C
    Oncogene; 2006 Oct; 25(50):6628-36. PubMed ID: 16715141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of differentiation in human colorectal carcinoma cell lines: epithelial-mesenchymal interactions.
    Richman PI; Bodmer WF
    J Pathol; 1988 Nov; 156(3):197-211. PubMed ID: 3204451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumorigenicity, mucin production and AM-3 epitope expression in clones selected from the HT-29 colon carcinoma cell line.
    Hanski C; Stolze B; Riecken EO
    Int J Cancer; 1992 Apr; 50(6):924-9. PubMed ID: 1372882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells.
    Velcich A; Palumbo L; Jarry A; Laboisse C; Racevskis J; Augenlicht L
    Cell Growth Differ; 1995 Jun; 6(6):749-57. PubMed ID: 7669730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of thymidylate synthase protein expression by Western blotting and immunohistochemistry on human colon carcinoma xenografts in nude mice.
    Derenzini M; Montanaro L; Chillà A; Tosti E; Ceccarelli C; Dall'Olio F; Ofner D; Treré D
    J Histochem Cytochem; 2002 Dec; 50(12):1633-40. PubMed ID: 12486085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of villin, a cytoskeletal protein specific to microvilli, in human ileum and colon and in colonic neoplasms.
    West AB; Isaac CA; Carboni JM; Morrow JS; Mooseker MS; Barwick KW
    Gastroenterology; 1988 Feb; 94(2):343-52. PubMed ID: 3335311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
    J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditionally immortalized colonic epithelial cell line from a Ptk6 null mouse that polarizes and differentiates in vitro.
    Whitehead RH; Robinson PS; Williams JA; Bie W; Tyner AL; Franklin JL
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1119-24. PubMed ID: 18205771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the activated p185erbB2 tyrosine kinase in human epithelial cells leads to MAP kinase activation but does not confer oncogenicity.
    Nowak F; Jacquemin-Sablon A; Pierre J
    Exp Cell Res; 1997 Mar; 231(2):251-9. PubMed ID: 9087165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of the human colon carcinoma cell line HCT-8 to methotrexate results in selection of cells with features of enterocytic differentiation.
    Barbat A; Pandrea I; Cambier D; Zweibaum A; Lesuffleur T
    Int J Cancer; 1998 Mar; 75(5):731-7. PubMed ID: 9495241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal human colon cells suppress malignancy when fused with colon cancer cells.
    Johnson TL; Moyer MP
    In Vitro Cell Dev Biol; 1990 Nov; 26(11):1095-100. PubMed ID: 2276997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
    Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
    Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype alteration in colon carcinoma cells: effect of in vivo passage?
    Maley MA; House AK; Jenkyn DJ; Sterrett G
    In Vitro Cell Dev Biol; 1991 May; 27A(5):363-8. PubMed ID: 1649163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells.
    Lesuffleur T; Barbat A; Dussaulx E; Zweibaum A
    Cancer Res; 1990 Oct; 50(19):6334-43. PubMed ID: 2205381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of human colon carcinoma.
    Brattain MG; Levine AE; Chakrabarty S; Yeoman LC; Willson JK; Long B
    Cancer Metastasis Rev; 1984; 3(3):177-91. PubMed ID: 6437669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.
    Meyer DL; Jungheim LN; Law KL; Mikolajczyk SD; Shepherd TA; Mackensen DG; Briggs SL; Starling JJ
    Cancer Res; 1993 Sep; 53(17):3956-63. PubMed ID: 8358723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.